ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

Contributed by: Business Wire

Logo

Tags

Science

Software

Biotechnology

Research

Health

Artificial Intelligence

Technology

Clinical Trials

Microsoft

More Like This

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report